These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Tetracycline therapy in pediatrics. Experiences with semisynthetic a new tetracycline derivative (Rondomycin)]. Schweier P Munch Med Wochenschr; 1967 Nov; 109(46):2425-9. PubMed ID: 5631662 [No Abstract] [Full Text] [Related]
3. Clinical pharmacology in Canada. Weyman SJ Int Z Klin Pharmakol Ther Toxikol; 1971 Oct; 5(2):135-8. PubMed ID: 5134630 [No Abstract] [Full Text] [Related]
4. Interferons for human neoplastic and viral diseases. Borden EC; Hawkins MJ Compr Ther; 1980 Oct; 6(10):6-15. PubMed ID: 6160944 [No Abstract] [Full Text] [Related]
5. [The use of cefotaxime in pediatrics: clinical and bacteriological experience]. Pavesio D; Pecco P; Viretto A; Ferrero R Minerva Pediatr; 1980 Dec; 32(23):1353-68. PubMed ID: 6261112 [No Abstract] [Full Text] [Related]
6. [Use of arginine in pediatrics]. Orsini A; Giraud F Ann Pediatr (Paris); 1965; 12(8):574-6. PubMed ID: 5855604 [No Abstract] [Full Text] [Related]
7. The interferons--Part 1. Freeman PR Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644 [No Abstract] [Full Text] [Related]
8. [Cephaloridine in pediatrics]. Monnet P Lyon Med; 1969 Jan; 221(3):105-15. PubMed ID: 5783013 [No Abstract] [Full Text] [Related]
9. [Lincomycin in pediatrics]. Monnet P Lyon Med; 1969 Jan; 221(3):123-9. PubMed ID: 5783015 [No Abstract] [Full Text] [Related]
10. [Use of antibiotics and chemotherapeutic agents in the pediatric practice]. Kienitz M; Mann G Dtsch Med J; 1972 Apr; 23(4):305-10. PubMed ID: 5044187 [No Abstract] [Full Text] [Related]
11. Interferons as therapeutic agents for infectious diseases. Bergman SJ; Ferguson MC; Santanello C Infect Dis Clin North Am; 2011 Dec; 25(4):819-34. PubMed ID: 22054758 [TBL] [Abstract][Full Text] [Related]
12. Nanomedicines in the future of pediatric therapy. Sosnik A; Carcaboso AM Adv Drug Deliv Rev; 2014 Jun; 73():140-61. PubMed ID: 24819219 [TBL] [Abstract][Full Text] [Related]
13. [The interferons: generalities]. Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B Tunis Med; 1998 Nov; 76(11):361-7. PubMed ID: 9881043 [No Abstract] [Full Text] [Related]
14. [Interferon - effects and therapeutic possibilities]. Strander H Nord Med; 1981 Mar; 96(3):82-3. PubMed ID: 6164976 [No Abstract] [Full Text] [Related]
16. Developments in pediatric infectious diseases: a review of WSPID 2013. Eley BS; Nuttall J Expert Rev Anti Infect Ther; 2014 Apr; 12(4):419-22. PubMed ID: 24579772 [No Abstract] [Full Text] [Related]
17. [Interferon one of the most interesting biological substances, but not a panacea]. Theml H; Siegert W; Ziegler HW; Huhn D Med Klin Prax; 1982 Feb; 77(5):14-21. PubMed ID: 6176839 [No Abstract] [Full Text] [Related]
18. Adverse drug reactions in hospitalized children in a department of infectious diseases. Fattahi F; Pourpak Z; Moin M; Kazemnejad A; Khotaei GT; Mamishi S; Siadati A; Tabatabaei P J Clin Pharmacol; 2005 Nov; 45(11):1313-8. PubMed ID: 16239365 [No Abstract] [Full Text] [Related]
19. Some thoughts on the clinical exploitation of interferon in infectious diseases. Tyrrell DA Interferon; 1982; 4():155-75. PubMed ID: 6195111 [No Abstract] [Full Text] [Related]
20. [Natural and recombinant interferons]. Läer S Med Monatsschr Pharm; 1999 Nov; 22(11):340-5. PubMed ID: 10596267 [No Abstract] [Full Text] [Related] [Next] [New Search]